NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Three pronged strategy to prevent mother to child transmission.

Damania K, Merchant RH, Arwari S, Gilada IS, Karkare J; International Conference on AIDS.

Int Conf AIDS. 1998; 12: 406 (abstract no. 23324).

Nowrosjee Wadia Maternity Hospital, Bombay, India.

OBJECTIVES: To study the efficacy of three pronged intervention strategy to reduce perinatal transmission of HIV 1 infection. DESIGN: Prospective, interventional study. METHODS: Interventional strategy in the form of antepartum zidovudine (ZDV) in a dosage of 100 mgs. qds for at least 7 weeks prior to delivery, elective caesarean section at term and no breast feeding (ZDV to infant for 6 weeks) was studied prospectively in 45 women accepting the same. Their babies were folowed-up clinically regularly and with HIV antibody testing at 9 months, 1 year, 15 months and 18 months interval. RESULTS: Of 40 women not accepting any interventional; 13 children remained seropositive at the end of 18 months. A transmission rate of 32.5% for our populance. Of the 18 babies who till date have followed up beyond 18 months; NO child has remained seropositive. All have become seronegative by 18 months. CONCLUSION: A three pronged intervention strategy to attack all periods of transmission in pregnancy (antenatal, intrapartum & postpartum) appears to be extremely effective. Antenatal ZDV in lower dosage and shorter period (at least 7 weeks) may be utilized in resource setting as in India amongst women offered and accepting the same.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Breast Feeding
  • Cesarean Section
  • Child
  • Delivery, Obstetric
  • Disease Transmission, Vertical
  • Female
  • HIV Antibodies
  • HIV Infections
  • Humans
  • India
  • Infant
  • Mothers
  • Pharmaceutical Preparations
  • Pregnancy
  • Prospective Studies
  • Zidovudine
  • surgery
  • transmission
Other ID:
  • 98395354
UI: 102228954

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov